| abstract |
A nanodispersion comprisesn (a) a membrane-forming molecule, (b) a coemulsifier and (c) a lipophilic component,n nin pharmaceutical end formulations, the nanodispersion being obtainable byn (α) mixing the components (a), (b) and (c) until a homogeneous clear liquid is obtained, and (β) adding the liquid obtained in step (α) to the water phase of the pharmaceutical end formulations, where steps (α) and (β) may be carried out without high energy mixing or homogenization. nn The nanodispersions prepared according to this invention are suitable as transport vehicles for pharmaceutical active agents. |